Skip to content

HIPER-500

A multicenter, randomized, double-blinded, parallel comparison, investigator-initiated, confirmatory clinical trial to evaluate the curative effect and safety of high-frequency (HIPER-500) stimulation in patients with subacute low back pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002734
Enrollment
120
Registered
2018-03-15
Start date
2017-02-28
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : This clinical trial for medical devices is conducted as a parallel study after randomized into the experimental device group or the control device group, and the allocation ratio of e

Sponsors

Samsung Medical Center
Lead Sponsor
Kangbuk Samsung Medical Center
Collaborator
Seoul Gangnam Wooridul Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Person who is aged 19 or more to less than 70, and complains subacute low back pain (1-6 months after developed). 2. Person who complains pain between 12th ribs and hips in terms of the range of low back pain. 3. Person who does not having radiating pain in infrapatellar areas within 3 days. 4. Person who does not take a spinal surgery within last 6 months. 5. Person who is not treated with steroid injection for the purpose of lumbar pain treatment within last 2 months. 6. Person who scores more than 30% in Oswestry Disability Index (ODI)(%). 7. Person who shows more than 4 in Numeric Rating Scale (NRS). 8. Person who any fracture or tumor is not observed after simple radiography

Exclusion criteria

Exclusion criteria: 1. Person who has neurological deficits of the lower extremity. 2. Based on pregnancy and urine test, person who tests positive, or is supposed to be pregnant during the study. 3. Person who has suffered from a heart disease before, or carries a pacemaker. 4. Person who inserts metallic aids into each body site (heart, bone, leg, foot, and waist, etc.). 5. Person who participates in other clinical trials or is supposed to do so during the study period. 6. Person who has a high fever (more than 38?) or turns out to be normal as a result of a blood test (leukocyte count 12,000 or more, and platelet count 50,000 or less). 7. Person who is not capable of taking part in the study because he cannot properly express the area of pain and the severity owing to cognitive hypofunction or impossibility of normal communication. 8. Person who is confirmed as an inadequate subject in participating in the study by other testers. 9. Person who is hard to apply physiotherapy devices or gel to his skin due to contact dermatitis.

Design outcomes

Primary

MeasureTime frame
Comparison between the Oswestry Disability Index(ODI) groups

Secondary

MeasureTime frame
Numeric Rating Scale(NRS) success rate, Comparison between the groups of Oswestry Disability Index(ODI) success rate (NRS success rate: the rate of patient reduced more than 50% after treatment compared to before treatment, ODI success rate: the rate of patient reduced more than 40% after treatment compared to before treatment) ;Comparison between the groups of Lumbar isometric endurance test (Sorensen test);Comparison between the groups of Up and Go test ;Comparison between the groups of Numeric Rating Scale (NRS) ;Numeric Rating Scale(NRS) success rate, Comparison between the groups of Oswestry Disability Index(ODI) success rate (NRS success rate: the rate of patient reduced more than 50% after treatment compared to before treatment, ODI success rate: the rate of patient reduced more than 40% after treatment compared to before treatment) ;Comparison between the groups with North American Spine Society(NASS) 4 point patients satisfaction index;Comparison between the groups of Lumbar isometric endurance test (Sorensen test);Comparison of drug administration frequency and quantity;Comparison between the groups of Up and Go test ;Based on the MRI result of back muscle, comparison of the alteration of T2 signal (using CNR), DWI signal (b=0, b=800), and ADC value, and comparison between the groups of these results.;Comparison between the groups with North American Spine Society(NASS) 4 point patients satisfaction index;Comparison of the muscle contraction latent period of the back muscle (erector spinae, multifidus) measured at the time of sudden motion of the upper limbs, and comparison between the groups of the period (Comparison between the groups of MRI and muscle contraction latent period is conducted, and it is supposed to be analyzed.) ;Based on the MIR result of back muscle, comparison of the alteration of T2 signal (using CNR), DWI signal (b=0, b=800), and ADC value, and comparison between the groups of these results

Countries

Korea, Republic of

Contacts

Public ContactMieun Kim

Samsung Medical Center

mieun2728.kim@samsung.com+82-70-7014-4176

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026